Dörken B - Search Results

1

NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.

Terwey TH, Vega-Ruiz A, Hemmati PG, Martus P, Dietz E, le Coutre P, Massenkeil G, Dörken B, Arnold R. Terwey TH, et al. Among authors: dorken b. Leukemia. 2012 Mar;26(3):536-42. doi: 10.1038/leu.2011.230. Epub 2011 Aug 26. Leukemia. 2012. PMID: 21869841 No abstract available.

2

NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia.

Terwey TH, Le Duc TM, Hemmati PG, le Coutre P, Nagy M, Martus P, Dörken B, Arnold R. Terwey TH, et al. Among authors: dorken b. Ann Oncol. 2013 May;24(5):1363-70. doi: 10.1093/annonc/mds615. Epub 2012 Dec 17. Ann Oncol. 2013. PMID: 23247660 Free article.

3

Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.

Vuong LG, Hemmati PG, Neuburger S, Terwey TH, Vulliamy T, Dokal I, le Coutre P, Dörken B, Arnold R. Vuong LG, et al. Among authors: dorken b. Acta Haematol. 2010;124(4):200-3. doi: 10.1159/000318721. Epub 2010 Nov 2. Acta Haematol. 2010. PMID: 21042011

4

Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML.

le Coutre P, Kreuzer KA, Massenkeil G, Baskaynak G, Zschieschang P, Genvresse I, Lupberger J, Mapara M, Dörken B, Arnold R. le Coutre P, et al. Among authors: dorken b. Leukemia. 2003 Dec;17(12):2525-6. doi: 10.1038/sj.leu.2403170. Leukemia. 2003. PMID: 14562118 No abstract available.

5

Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias.

Massenkeil G, Nagy M, Neuburger S, Tamm I, Lutz C, le Coutre P, Rosen O, Wernecke KD, Dörken B, Arnold R. Massenkeil G, et al. Among authors: dorken b. Bone Marrow Transplant. 2005 Oct;36(8):683-9. doi: 10.1038/sj.bmt.1705123. Bone Marrow Transplant. 2005. PMID: 16113673

6

Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.

Hemmati PG, Pfeifer K, Vuong LG, Jehn CF, Terwey TH, le Coutre P, Dörken B, Arnold R. Hemmati PG, et al. Among authors: dorken b. Bone Marrow Transplant. 2018 Jan;53(1):101-103. doi: 10.1038/bmt.2017.215. Epub 2017 Oct 9. Bone Marrow Transplant. 2018. PMID: 28991253 No abstract available.

7

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dörken B, Arnold R. Massenkeil G, et al. Among authors: dorken b. Bone Marrow Transplant. 2002 Dec;30(12):899-903. doi: 10.1038/sj.bmt.1703737. Bone Marrow Transplant. 2002. PMID: 12476283

8

Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved.

Massenkeil G, Nagy M, Lawang M, Rosen O, Genvresse I, Geserick G, Dörken B, Arnold R. Massenkeil G, et al. Among authors: dorken b. Bone Marrow Transplant. 2003 Mar;31(5):339-45. doi: 10.1038/sj.bmt.1703859. Bone Marrow Transplant. 2003. PMID: 12634724

9

Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy.

Terwey TH, Massenkeil G, Tamm I, Hemmati PG, Neuburger S, Martus P, Dörken B, Hoelzer D, Arnold R. Terwey TH, et al. Among authors: dorken b. Bone Marrow Transplant. 2008 Dec;42(12):791-8. doi: 10.1038/bmt.2008.258. Epub 2008 Aug 18. Bone Marrow Transplant. 2008. PMID: 18711350

10

Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.

Massenkeil G, Roigas J, Nagy M, Wille A, Stroszczynski C, Mapara MY, Loening S, Dörken B, Arnold R. Massenkeil G, et al. Among authors: dorken b. Bone Marrow Transplant. 2004 Aug;34(4):309-16. doi: 10.1038/sj.bmt.1704587. Bone Marrow Transplant. 2004. PMID: 15220955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters